10-Q 1 ful20240601_10q.htm FORM 10-Q ful20240601_10q.htm
0000039368 FULLER H B CO false --11-30 Q2 2024 12,523 11,080 0 0 10,045,900 10,045,900 1.00 1.00 160,000,000 160,000,000 54,507,836 54,092,987 66,144 3,946 16,469 66,982 1,460 17,744 307,173 300,000 5 0 3 false false false false Consistent with our internal management reporting, Corporate Unallocated amounts in the tables above include charges that are not allocated to the Company’s reportable segments. 00000393682023-12-032024-06-01 xbrli:shares 00000393682024-06-21 iso4217:USD 00000393682024-03-032024-06-01 00000393682023-03-052023-06-03 00000393682022-12-042023-06-03 iso4217:USDxbrli:shares 0000039368us-gaap:InterestRateSwapMember2024-03-032024-06-01 0000039368us-gaap:InterestRateSwapMember2023-03-052023-06-03 0000039368us-gaap:InterestRateSwapMember2023-12-032024-06-01 0000039368us-gaap:InterestRateSwapMember2022-12-042023-06-03 0000039368ful:NetInvestmentHedgesMember2024-03-032024-06-01 0000039368ful:NetInvestmentHedgesMember2023-03-052023-06-03 0000039368ful:NetInvestmentHedgesMember2023-12-032024-06-01 0000039368ful:NetInvestmentHedgesMember2022-12-042023-06-03 00000393682024-06-01 00000393682023-12-02 0000039368us-gaap:CommonStockMember2023-12-02 0000039368us-gaap:AdditionalPaidInCapitalMember2023-12-02 0000039368us-gaap:RetainedEarningsMember2023-12-02 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-02 0000039368us-gaap:NoncontrollingInterestMember2023-12-02 0000039368us-gaap:CommonStockMember2023-12-032024-03-02 0000039368us-gaap:AdditionalPaidInCapitalMember2023-12-032024-03-02 0000039368us-gaap:RetainedEarningsMember2023-12-032024-03-02 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-032024-03-02 0000039368us-gaap:NoncontrollingInterestMember2023-12-032024-03-02 00000393682023-12-032024-03-02 0000039368us-gaap:CommonStockMember2024-03-02 0000039368us-gaap:AdditionalPaidInCapitalMember2024-03-02 0000039368us-gaap:RetainedEarningsMember2024-03-02 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-02 0000039368us-gaap:NoncontrollingInterestMember2024-03-02 00000393682024-03-02 0000039368us-gaap:CommonStockMember2024-03-032024-06-01 0000039368us-gaap:AdditionalPaidInCapitalMember2024-03-032024-06-01 0000039368us-gaap:RetainedEarningsMember2024-03-032024-06-01 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-032024-06-01 0000039368us-gaap:NoncontrollingInterestMember2024-03-032024-06-01 0000039368us-gaap:CommonStockMember2024-06-01 0000039368us-gaap:AdditionalPaidInCapitalMember2024-06-01 0000039368us-gaap:RetainedEarningsMember2024-06-01 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-01 0000039368us-gaap:NoncontrollingInterestMember2024-06-01 0000039368us-gaap:CommonStockMember2022-12-03 0000039368us-gaap:AdditionalPaidInCapitalMember2022-12-03 0000039368us-gaap:RetainedEarningsMember2022-12-03 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-03 0000039368us-gaap:NoncontrollingInterestMember2022-12-03 00000393682022-12-03 0000039368us-gaap:CommonStockMember2022-12-042023-03-04 0000039368us-gaap:AdditionalPaidInCapitalMember2022-12-042023-03-04 0000039368us-gaap:RetainedEarningsMember2022-12-042023-03-04 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-042023-03-04 0000039368us-gaap:NoncontrollingInterestMember2022-12-042023-03-04 00000393682022-12-042023-03-04 0000039368us-gaap:CommonStockMember2023-03-04 0000039368us-gaap:AdditionalPaidInCapitalMember2023-03-04 0000039368us-gaap:RetainedEarningsMember2023-03-04 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-04 0000039368us-gaap:NoncontrollingInterestMember2023-03-04 00000393682023-03-04 0000039368us-gaap:CommonStockMember2023-03-052023-06-03 0000039368us-gaap:AdditionalPaidInCapitalMember2023-03-052023-06-03 0000039368us-gaap:RetainedEarningsMember2023-03-052023-06-03 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-052023-06-03 0000039368us-gaap:NoncontrollingInterestMember2023-03-052023-06-03 0000039368us-gaap:CommonStockMember2023-06-03 0000039368us-gaap:AdditionalPaidInCapitalMember2023-06-03 0000039368us-gaap:RetainedEarningsMember2023-06-03 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-03 0000039368us-gaap:NoncontrollingInterestMember2023-06-03 00000393682023-06-03 0000039368ful:NdIndustriesMemberful:EngineeringAdhesivesMember2024-05-202024-05-20 0000039368ful:NdIndustriesMember2024-06-01 0000039368ful:NdIndustriesMemberus-gaap:CustomerRelationshipsMember2024-06-01 0000039368ful:NdIndustriesMemberus-gaap:TrademarksAndTradeNamesMember2024-06-01 0000039368ful:NdIndustriesMemberus-gaap:TechnologyBasedIntangibleAssetsMember2024-06-01 0000039368ful:NdIndustriesMemberful:EngineeringAdhesivesMember2024-05-20 iso4217:GBP 0000039368ful:CertainAssetsOfTheSanglierGroupMemberful:ConstructionAdhesivesMember2023-09-082023-09-08 0000039368ful:CertainAssetsOfTheSanglierGroupMemberful:ConstructionAdhesivesMember2024-03-02 0000039368ful:AdhezionMember2023-06-232023-06-23 0000039368ful:AdhezionMember2023-06-23 0000039368ful:AdhezionMember2024-03-02 0000039368ful:XchemMember2023-06-122023-06-12 0000039368ful:XchemMember2024-03-02 0000039368ful:BeardowAdamsMember2023-05-012023-05-01 0000039368ful:BeardowAdamsMember2024-03-02 0000039368ful:AspenResearchCorporationMember2023-01-312023-01-31 0000039368ful:AspenResearchCorporationMember2023-12-02 iso4217:EUR 0000039368ful:LemtapesMember2022-12-152022-12-15 0000039368ful:LemtapesMember2023-12-02 0000039368srt:MinimumMember2023-12-032024-06-01 0000039368srt:MaximumMember2023-12-032024-06-01 0000039368us-gaap:CostOfSalesMember2024-03-032024-06-01 0000039368us-gaap:CostOfSalesMember2023-03-052023-06-03 0000039368us-gaap:CostOfSalesMember2023-12-032024-06-01 0000039368us-gaap:CostOfSalesMember2022-12-042023-06-03 0000039368us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-03-032024-06-01 0000039368us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-03-052023-06-03 0000039368us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-12-032024-06-01 0000039368us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-12-042023-06-03 0000039368ful:EmployeeRelatedMember2022-12-03 0000039368ful:AssetRelatedMember2022-12-03 0000039368us-gaap:OtherRestructuringMember2022-12-03 0000039368ful:EmployeeRelatedMember2022-12-042023-12-02 0000039368ful:AssetRelatedMember2022-12-042023-12-02 0000039368us-gaap:OtherRestructuringMember2022-12-042023-12-02 00000393682022-12-042023-12-02 0000039368ful:EmployeeRelatedMember2023-12-02 0000039368ful:AssetRelatedMember2023-12-02 0000039368us-gaap:OtherRestructuringMember2023-12-02 0000039368ful:EmployeeRelatedMember2023-12-032024-06-01 0000039368ful:AssetRelatedMember2023-12-032024-06-01 0000039368us-gaap:OtherRestructuringMember2023-12-032024-06-01 0000039368ful:EmployeeRelatedMember2024-06-01 0000039368ful:AssetRelatedMember2024-06-01 0000039368us-gaap:OtherRestructuringMember2024-06-01 0000039368ful:HygieneHealthAndConsumableAdhesivesMember2023-12-02 0000039368ful:EngineeringAdhesivesMember2023-12-02 0000039368ful:ConstructionAdhesivesMember2023-12-02 0000039368ful:HygieneHealthAndConsumableAdhesivesMember2023-12-032024-06-01 0000039368ful:EngineeringAdhesivesMember2023-12-032024-06-01 0000039368ful:ConstructionAdhesivesMember2023-12-032024-06-01 0000039368ful:HygieneHealthAndConsumableAdhesivesMember2024-06-01 0000039368ful:EngineeringAdhesivesMember2024-06-01 0000039368ful:ConstructionAdhesivesMember2024-06-01 0000039368ful:PurchasedTechnologyAndPatentsMember2024-06-01 0000039368us-gaap:CustomerRelationshipsMember2024-06-01 0000039368us-gaap:TradeNamesMember2024-06-01 0000039368us-gaap:OtherIntangibleAssetsMember2024-06-01 0000039368ful:PurchasedTechnologyAndPatentsMember2023-12-02 0000039368us-gaap:CustomerRelationshipsMember2023-12-02 0000039368us-gaap:TradeNamesMember2023-12-02 0000039368us-gaap:OtherIntangibleAssetsMember2023-12-02 0000039368ful:TermLoanBMember2024-03-04 0000039368ful:TermLoanBFirstTrancheMember2024-03-04 0000039368ful:AmendedTermLoanBMember2024-03-04 xbrli:pure 0000039368ful:AmendedTermLoanBMember2024-03-042024-03-04 0000039368ful:AmendedTermLoanBMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-03-042024-03-04 0000039368ful:AmendedTermLoanBMemberus-gaap:PrimeRateMember2024-03-042024-03-04 0000039368ful:TermLoanBMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-03-042024-03-04 0000039368ful:TermLoanBMembersrt:MinimumMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-03-042024-03-04 0000039368ful:TermLoanBMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-06-012024-06-01 0000039368country:USus-gaap:PensionPlansDefinedBenefitMember2024-03-032024-06-01 0000039368country:USus-gaap:PensionPlansDefinedBenefitMember2023-03-052023-06-03 0000039368us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-032024-06-01 0000039368us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2023-03-052023-06-03 0000039368us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-03-032024-06-01 0000039368us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-03-052023-06-03 0000039368country:US2024-03-032024-06-01 0000039368country:US2023-03-052023-06-03 0000039368us-gaap:ForeignPlanMember2024-03-032024-06-01 0000039368us-gaap:ForeignPlanMember2023-03-052023-06-03 0000039368country:USus-gaap:PensionPlansDefinedBenefitMember2023-12-032024-06-01 0000039368country:USus-gaap:PensionPlansDefinedBenefitMember2022-12-042023-06-03 0000039368us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-032024-06-01 0000039368us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-042023-06-03 0000039368us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-12-032024-06-01 0000039368us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-042023-06-03 0000039368country:US2023-12-032024-06-01 0000039368country:US2022-12-042023-06-03 0000039368us-gaap:ForeignPlanMember2023-12-032024-06-01 0000039368us-gaap:ForeignPlanMember2022-12-042023-06-03 0000039368ful:NetInvestmentHedgeMember2024-03-032024-06-01 0000039368ful:NetInvestmentHedgeMember2023-03-052023-06-03 0000039368ful:NetInvestmentHedgeMember2023-12-032024-06-01 0000039368ful:NetInvestmentHedgeMember2022-12-042023-06-03 0000039368us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-032024-06-01 0000039368us-gaap:AccumulatedTranslationAdjustmentMember2023-12-032024-06-01 0000039368us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember2023-12-032024-06-01 0000039368us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-032024-06-01 0000039368us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-032024-06-01 0000039368us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember2023-12-032024-06-01 0000039368us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-12-032024-06-01 0000039368us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-032024-06-01 0000039368us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2023-12-032024-06-01 0000039368ful:NetInvestmentHedgesMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-12-032024-06-01 0000039368ful:NetInvestmentHedgesMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-032024-06-01 0000039368ful:NetInvestmentHedgesMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2023-12-032024-06-01 0000039368us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-12-032024-06-01 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-032024-06-01 0000039368us-gaap:AociAttributableToNoncontrollingInterestMember2023-12-032024-06-01 0000039368us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-06-01 0000039368us-gaap:AociAttributableToNoncontrollingInterestMember2024-06-01 0000039368us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-12-042023-12-02 0000039368us-gaap:AccumulatedTranslationAdjustmentMember2022-12-042023-12-02 0000039368us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember2022-12-042023-12-02 0000039368us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-12-042023-12-02 0000039368us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-042023-12-02 0000039368us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember2022-12-042023-12-02 0000039368us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-12-042023-12-02 0000039368us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-042023-12-02 0000039368us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2022-12-042023-12-02 0000039368ful:NetInvestmentHedgesMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-042023-12-02 0000039368ful:NetInvestmentHedgesMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-12-042023-12-02 0000039368ful:NetInvestmentHedgesMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2022-12-042023-12-02 0000039368us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-12-042023-12-02 0000039368us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-042023-12-02 0000039368us-gaap:AociAttributableToNoncontrollingInterestMember2022-12-042023-12-02 0000039368us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-12-02 0000039368us-gaap:AociAttributableToNoncontrollingInterestMember2023-12-02 0000039368us-gaap:InterestRateSwapMember2023-01-12 0000039368us-gaap:InterestRateSwapMember2023-02-28 0000039368us-gaap:InterestRateSwapMember2024-06-01 0000039368ful:InterestRateSwap2Member2023-03-16 0000039368ful:InterestRateSwap2Member2024-06-01 0000039368ful:InterestRateSwap3Member2023-03-16 0000039368ful:InterestRateSwap3Member2024-06-01 0000039368us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-03-032024-06-01 0000039368us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-03-052023-06-03 0000039368us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-032024-06-01 0000039368us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-042023-06-03 0000039368ful:InterestRateSwapRelatedToPublicNotesMember2021-02-12 0000039368ful:InterestRateSwapRelatedToPublicNotesMemberful:LondonInterbankOfferedRateLibor1Member2021-02-12 0000039368ful:InterestRateSwapRelatedToPublicNotesMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-06-30 0000039368ful:InterestRateSwapRelatedToPublicNotesMember2024-06-01 0000039368ful:PublicNotesMember2024-06-01 0000039368us-gaap:CrossCurrencyInterestRateContractMember2022-10-17 0000039368us-gaap:CrossCurrencyInterestRateContractMember2022-10-20 0000039368us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-06-30 0000039368us-gaap:CrossCurrencyInterestRateContractMemberful:EuroShortTermRateESTROvernightIndexSwapRateMember2023-07-17 0000039368us-gaap:CrossCurrencyInterestRateContractMember2024-06-01 0000039368us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2023-12-032024-06-01 0000039368us-gaap:FairValueMeasurementsRecurringMember2024-06-01 0000039368us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-01 0000039368us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-01 0000039368us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-01 0000039368us-gaap:FairValueMeasurementsRecurringMember2023-12-02 0000039368us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-02 0000039368us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-02 0000039368us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-02 0000039368ful:TissueSealLLCMember2024-06-01 0000039368ful:GssiSealantsIncMember2023-12-032024-03-02 0000039368ful:ContingentConsiderationLiabilityMember2023-12-02 0000039368ful:ContingentConsiderationLiabilityMember2023-12-032024-06-01 0000039368ful:ContingentConsiderationLiabilityMember2024-06-01 0000039368ful:FacilityInSimpsonvilleSouthCarolinaMember2024-06-01 0000039368ful:FacilityInSimpsonvilleSouthCarolinaMember2023-12-02 0000039368ful:AsbestosRelatedLawsuitsAndClaimsMember2023-12-032024-06-01 0000039368ful:AsbestosRelatedLawsuitsAndClaimsMember2022-12-042023-06-03 0000039368ful:AsbestosRelatedLawsuitsAndClaimsMember2020-12-032023-12-02 0000039368ful:AsbestosRelatedLawsuitsAndClaimsMember2024-06-01 0000039368ful:AsbestosRelatedLawsuitsAndClaimsMember2023-06-03 0000039368ful:AsbestosRelatedLawsuitsAndClaimsMember2023-12-02 0000039368ful:The2022ShareRepurchaseProgramMember2022-04-22 utr:Y 0000039368ful:The2022ShareRepurchaseProgramMember2022-04-222022-04-22 0000039368ful:The2022ShareRepurchaseProgramMember2024-03-032024-06-01 0000039368ful:The2022ShareRepurchaseProgramMemberus-gaap:CommonStockMember2024-03-032024-06-01 0000039368ful:The2022ShareRepurchaseProgramMemberus-gaap:AdditionalPaidInCapitalMember2024-03-032024-06-01 0000039368ful:The2022ShareRepurchaseProgramMember2023-12-032024-03-02 0000039368ful:The2022ShareRepurchaseProgramMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:TotalSegmentMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:TotalSegmentMember2023-03-052023-06-03 0000039368us-gaap:CorporateNonSegmentMember2024-03-032024-06-01 0000039368us-gaap:CorporateNonSegmentMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:TotalSegmentMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:TotalSegmentMember2022-12-042023-06-03 0000039368us-gaap:CorporateNonSegmentMember2023-12-032024-06-01 0000039368us-gaap:CorporateNonSegmentMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMembersrt:AmericasMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMembersrt:AmericasMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMembersrt:AmericasMember2024-03-032024-06-01 0000039368us-gaap:CorporateNonSegmentMembersrt:AmericasMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMemberful:EIMEAMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMemberful:EIMEAMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMemberful:EIMEAMember2024-03-032024-06-01 0000039368us-gaap:CorporateNonSegmentMemberful:EIMEAMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMembersrt:AsiaPacificMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMembersrt:AsiaPacificMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMembersrt:AsiaPacificMember2024-03-032024-06-01 0000039368us-gaap:CorporateNonSegmentMembersrt:AsiaPacificMember2024-03-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMembersrt:AmericasMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMembersrt:AmericasMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMembersrt:AmericasMember2023-03-052023-06-03 0000039368us-gaap:CorporateNonSegmentMembersrt:AmericasMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMemberful:EIMEAMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMemberful:EIMEAMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMemberful:EIMEAMember2023-03-052023-06-03 0000039368us-gaap:CorporateNonSegmentMemberful:EIMEAMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMembersrt:AsiaPacificMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMembersrt:AsiaPacificMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMembersrt:AsiaPacificMember2023-03-052023-06-03 0000039368us-gaap:CorporateNonSegmentMembersrt:AsiaPacificMember2023-03-052023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMembersrt:AmericasMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMembersrt:AmericasMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMembersrt:AmericasMember2023-12-032024-06-01 0000039368us-gaap:CorporateNonSegmentMembersrt:AmericasMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMemberful:EIMEAMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMemberful:EIMEAMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMemberful:EIMEAMember2023-12-032024-06-01 0000039368us-gaap:CorporateNonSegmentMemberful:EIMEAMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMembersrt:AsiaPacificMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMembersrt:AsiaPacificMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMembersrt:AsiaPacificMember2023-12-032024-06-01 0000039368us-gaap:CorporateNonSegmentMembersrt:AsiaPacificMember2023-12-032024-06-01 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMembersrt:AmericasMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMembersrt:AmericasMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMembersrt:AmericasMember2022-12-042023-06-03 0000039368us-gaap:CorporateNonSegmentMembersrt:AmericasMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMemberful:EIMEAMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMemberful:EIMEAMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMemberful:EIMEAMember2022-12-042023-06-03 0000039368us-gaap:CorporateNonSegmentMemberful:EIMEAMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:HygieneHealthAndConsumableAdhesivesMembersrt:AsiaPacificMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:EngineeringAdhesivesMembersrt:AsiaPacificMember2022-12-042023-06-03 0000039368us-gaap:OperatingSegmentsMemberful:ConstructionAdhesivesMembersrt:AsiaPacificMember2022-12-042023-06-03 0000039368us-gaap:CorporateNonSegmentMembersrt:AsiaPacificMember2022-12-042023-06-03 thunderdome:item
 
 

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 1, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                              to                                 .

 

Commission file number: 001-09225

 

H.B. FULLER COMPANY

(Exact name of registrant as specified in its charter)

 

Minnesota41-0268370
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization)Identification No.)

                                                                             

1200 Willow Lake Boulevard, St. Paul, Minnesota55110-5101
(Address of principal executive offices)(Zip Code)

                                                                                                                           

Registrant’s telephone number, including area code: (651) 236-5900

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to section 12(b) of the Act:

 

 Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $1.00 per share

     FUL

New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

                    

Large accelerated filerAccelerated filer ☐
Non-accelerated filer ☐Smaller reporting company

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12(b) of the Exchange Act. Yes No ☒

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PROCEEDING FIVE YEARS:

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☐ No ☐

 

APPLICABLE ONLY TO CORPORATE ISSUERS

 

The number of shares outstanding of the Registrant’s Common Stock, par value $1.00 per share, was 54,521,587 as of June 21, 2024.

 

 

 

 

H.B. Fuller Company

Quarterly Report on Form 10-Q

Table of Contents

 

   

Page

PART 1. FINANCIAL INFORMATION

 
     

ITEM 1.

FINANCIAL STATEMENTS (Unaudited)

3

     
 

Consolidated Statements of Income for the three and six months ended June 1, 2024 and June 3, 2023

3

     
 

Consolidated Statements of Comprehensive Income for the three and six months ended June 1, 2024 and June 3, 2023

4

     
 

Consolidated Balance Sheets as of June 1, 2024 and December 2, 2023

5

     
 

Consolidated Statements of Total Equity for the three months and six months ended June 1, 2024 and June 3, 2023

6

     
 

Consolidated Statements of Cash Flows for the six months ended June 1, 2024 and June 3, 2023

7

     
 

Notes to Consolidated Financial Statements

8

     

ITEM 2.

MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

21

     

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

32

     

ITEM 4.

CONTROLS AND PROCEDURES

32

     

PART II. OTHER INFORMATION

33

     

ITEM 1.

LEGAL PROCEEDINGS

33

     

ITEM 1A.

RISK FACTORS

33

     

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

34

     

ITEM 6.

EXHIBITS

34

     

SIGNATURES

35

 

 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

H.B. FULLER COMPANY AND SUBSIDIARIES

Consolidated Statements of Income

(In thousands, except per share amounts)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 1,

   

June 3,

   

June 1,

   

June 3,

 
   

2024

   

2023

   

2024

   

2023

 

Net revenue

  $ 917,107     $ 898,239     $ 1,727,525     $ 1,707,421  

Cost of sales

    (635,055 )     (641,464 )     (1,206,237 )     (1,235,838 )

Gross profit

    282,052       256,775       521,288       471,583  

Selling, general and administrative expenses

    (181,456 )     (166,625 )     (353,817 )     (321,167 )

Other income, net

    3,634       605       5,135       3,209  

Interest expense

    (32,314 )     (33,131 )     (64,216 )     (66,200 )

Interest income

    1,199       932       2,506       1,599  

Income before income taxes and income from equity method investments

    73,115       58,556       110,896       89,024  

Income taxes

    (22,418 )     (19,291 )     (30,231 )     (29,024 )

Income from equity method investments

    600       1,157       1,644       2,338  

Net income including non-controlling interest

    51,297       40,422       82,309       62,338  

Net income attributable to non-controlling interest

    (33 )     (21 )     (54 )     (48 )

Net income attributable to H.B. Fuller

  $ 51,264     $ 40,401     $ 82,255     $ 62,290  
                                 

Earnings per share attributable to H.B. Fuller common stockholders:

                               

Basic

  $ 0.93     $ 0.74     $ 1.50     $ 1.15  

Diluted

  $ 0.91     $ 0.73     $ 1.45     $ 1.12  
                                 

Weighted-average common shares outstanding:

                               

Basic

    54,946       54,269       54,824       54,222  

Diluted

    56,636       55,717       56,604       55,818  
                                 

Dividends declared per common share

  $ 0.223     $ 0.205     $ 0.428     $ 0.395  

 

See accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

H.B. FULLER COMPANY AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

 

  

Three Months Ended

  

Six Months Ended

 
  

June 1,

  

June 3,

  

June 1,

  

June 3,

 
  

2024

  

2023

  

2024

  

2023

 

Net income including non-controlling interest

 $51,297  $40,422  $82,309  $62,338 

Other comprehensive (loss) income

                

Foreign currency translation

  (26,926)  26,410   (46,288)  22,774 

Defined benefit pension plans adjustment, net of tax

  419   858   2,538   1,709 

Interest rate swaps, net of tax

  10,196   (9,488)  7,731   (1,153)

Net investment hedges, net of tax

  123   (5,384)  3,913   (5,683)

Other comprehensive (loss) income

  (16,188)  12,396   (32,106)  17,647 

Comprehensive income

  35,109   52,818   50,203   79,985 

Less: Comprehensive income attributable to non-controlling interest

  1   6   13   43 

Comprehensive income attributable to H.B. Fuller

 $35,108  $52,812  $50,190  $79,942 

 

See accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

H.B. FULLER COMPANY AND SUBSIDIARIES

Consolidated Balance Sheets

(In thousands, except share and per share amounts)

(Unaudited)

 

  

June 1,

  

December 2,

 
  

2024

  

2023

 

Assets

        

Current assets:

        

Cash and cash equivalents

 $114,823  $179,453 

Trade receivables (net of allowances of $12,523 and $11,080, as of June 1, 2024 and December 2, 2023, respectively)

  571,134   577,932 

Inventories

  496,085   442,040 

Other current assets

  109,021   112,678 

Total current assets

  1,291,063   1,312,103 
         

Property, plant and equipment

  1,813,723   1,755,035 

Accumulated depreciation

  (974,875)  (930,380)

Property, plant and equipment, net

  838,848   824,655 
         

Goodwill

  1,578,297   1,486,512 

Other intangibles, net

  813,063   729,140 

Other assets

  397,839   371,165 

Total assets

 $4,919,110  $4,723,575 
         

Liabilities, non-controlling interest and total equity

        

Current liabilities

        

Notes payable

 $1,396  $1,841 

Trade payables

  474,095   439,700 

Accrued compensation

  78,343   95,680 

Income taxes payable

  46,883   47,688 

Other accrued expenses

  83,350   107,902 

Total current liabilities

  684,067   692,811 
         

Long-term debt

  2,023,520   1,836,590 

Accrued pension liabilities

  50,848   50,189 

Other liabilities

  368,561   388,072 

Total liabilities

 $3,126,996  $2,967,662 
         

Commitments and contingencies (Note 13)

          
         

Equity

        

H.B. Fuller stockholders' equity:

        

Preferred stock (no shares outstanding) shares authorized – 10,045,900

  -   - 

Common stock, par value $1.00 per share, shares authorized – 160,000,000, shares outstanding – 54,507,836 and 54,092,987 as of June 1, 2024 and December 2, 2023, respectively

 $54,508  $54,093 

Additional paid-in capital

  310,458   301,485 

Retained earnings

  1,901,372   1,842,507 

Accumulated other comprehensive loss

  (474,945)  (442,880)

Total H.B. Fuller stockholders' equity

  1,791,393   1,755,205 

Non-controlling interest

  721   708 

Total equity

  1,792,114   1,755,913 

Total liabilities, non-controlling interest and total equity

 $4,919,110  $4,723,575 

 

 See accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

H.B. FULLER COMPANY AND SUBSIDIARIES

Consolidated Statements of Total Equity

(In thousands)

(Unaudited)

 

   

H.B. Fuller Company Shareholders

                 
                           

Accumulated

                 
           

Additional

           

Other

                 
   

Common

   

Paid-in

   

Retained

   

Comprehensive

   

Non-Controlling

         
   

Stock

   

Capital

   

Earnings

   

Income (Loss)

   

Interest

   

Total

 
                                                 

Balance at December 2, 2023

  $ 54,093     $ 301,485     $ 1,842,507     $ (442,880 )   $ 708     $ 1,755,913  

Comprehensive income

    -       -       30,991       (15,909 )     12       15,094  

Dividends

    -       -       (11,246 )     -       -       (11,246 )

Stock option exercises

    200       8,777       -       -       -       8,977  

Share-based compensation plans and other, net

    225       5,490       -       -       -       5,715  

Repurchases of common stock

    (80 )     (6,128 )     -       -       -       (6,208 )

Balance at March 2, 2024

  $ 54,438     $ 309,624     $ 1,862,252     $ (458,789 )   $ 720     $ 1,768,245  

Comprehensive income

    -       -       51,264       (16,156 )     1       35,109  

Dividends

    -       -       (12,144 )     -       -       (12,144 )

Stock option exercises

    189       9,123       -       -       -       9,312  

Share-based compensation plans and other, net

    81       7,111       -       -       -       7,192  

Repurchases of common stock

    (200 )     (15,400 )     -       -       -       (15,600 )

Balance at June 1, 2024

  $ 54,508     $ 310,458     $ 1,901,372     $ (474,945 )   $ 721     $ 1,792,114  

 

   

H.B. Fuller Company Shareholders

                 
                           

Accumulated

                 
           

Additional

           

Other

                 
   

Common

   

Paid-in

   

Retained

   

Comprehensive

   

Non-Controlling

         
   

Stock

   

Capital

   

Earnings

   

Income (Loss)

   

Interest

   

Total

 
                                                 

Balance at December 3, 2022

  $ 53,677     $ 266,491     $ 1,741,359     $ (451,357 )   $ 624     $ 1,610,794  

Comprehensive income

    -       -       21,889       5,241       37       27,167  

Dividends

    -       -       (10,305 )     -       -       (10,305 )

Stock option exercises

    76       3,520       -       -       -       3,596  

Share-based compensation plans and other, net

    102       5,221       -       -       -       5,323  

Repurchases of common stock

    (36 )     (2,412 )     -       -       -       (2,448 )

Balance at March 4, 2023

  $ 53,819     $ 272,820     $ 1,752,943     $ (446,116 )   $ 661     $ 1,634,127  

Comprehensive income (loss)

    -       -       40,401       12,411       6       52,818  

Dividends

    -       -       (11,129 )     -       -       (11,129 )

Stock option exercises

    13       584       -       -       -       597  

Share-based compensation plans other, net

    30       6,818       -       -       -       6,848  

Repurchases of common stock

    (2 )     (102 )     -       -       -       (104 )

Balance at June 3, 2023

  $ 53,860     $ 280,120     $ 1,782,215     $ (433,705 )   $ 667     $ 1,683,157  

 

See accompanying Notes to Unaudited Consolidated Financial Statements. 

 

 

H.B. FULLER COMPANY AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

   

Six Months Ended

 
   

June 1, 2024

   

June 3, 2023

 

Cash flows from operating activities:

               

Net income including non-controlling interest

  $ 82,309     $ 62,338  

Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:

               

Depreciation

    45,099       39,163  

Amortization

    39,574       37,813  

Deferred income taxes

    (24,117 )     (16,831 )

Income from equity method investments, net of dividends received

    (1,644 )     (2,338 )

Debt issuance costs write-off

    -       2,689  

Loss on fair value adjustment on contingent consideration liability

    -       (220 )

Gain on sale or disposal of assets

    (166 )     (42 )

Share-based compensation

    11,930       10,953  

Pension and other post-retirement benefit plan activity

    (4,370 )     (6,226 )

Change in assets and liabilities, net of effects of acquisitions:

               

Trade receivables, net

    22,639       66,896  

Inventories

    (56,512 )     8,285  

Other assets

    (22,328 )     (36,951 )

Trade payables

    38,781       (20,301 )

Accrued compensation

    (16,424 )     (42,190 )

Other accrued expenses

    (7,002 )     (9,988 )

Income taxes payable

    (11,218 )     10,025  

Other liabilities

    (1,786 )     18,819  

Other

    34,210       (13,497 )

Net cash provided by operating activities

    128,975       108,397  
                 

Cash flows from investing activities:

               

Purchased property, plant and equipment

    (90,181 )     (82,578 )

Purchased businesses, net of cash acquired

    (254,287 )     (103,744 )

Proceeds from sale of property, plant and equipment

    694       2,623  

Net cash used in investing activities

    (343,774 )     (183,699 )
                 

Cash flows from financing activities:

               

Proceeds from issuance of long-term debt

    1,497,000       1,300,000  

Repayment of long-term debt

    (1,305,500 )     (1,176,650 )

Payment of debt issuance costs

    (3,493 )     (10,214 )

Net payment of notes payable

    (376 )     (239 )

Dividends paid

    (23,295 )     (21,258 )

Proceeds from stock options exercised

    18,289       4,193  

Repurchases of common stock

    (21,809 )     (2,552 )

Net cash provided by financing activities

    160,816       93,280  
                 

Effect of exchange rate changes on cash and cash equivalents

    (10,647 )     5,295  

Net change in cash and cash equivalents

    (64,630 )     23,273  

Cash and cash equivalents at beginning of period

    179,453       79,910  

Cash and cash equivalents at end of period

  $ 114,823     $ 103,183  

 

See accompanying Notes to Unaudited Consolidated Financial Statements.

 

 

H.B. FULLER COMPANY AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Amounts in thousands, except per share amounts)

(Unaudited)

 

Note 1: Basis of Presentation

 

Overview

 

The accompanying unaudited interim Consolidated Financial Statements of H.B. Fuller Company and Subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information necessary for a fair presentation of results of operations, comprehensive income, financial position and cash flows in conformity with U.S. generally accepted accounting principles. In our opinion, the unaudited interim Consolidated Financial Statements reflect all adjustments of a normal recurring nature considered necessary for the fair presentation of the results for the periods presented. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole.

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from these estimates. These unaudited interim Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in our Annual Report on Form 10-K for the year ended  December 2, 2023 as filed with the Securities and Exchange Commission.

 

New Accounting Pronouncements

 

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. This ASU provides new disclosure requirements including presentation of prescribed line items in the effective tax rate reconciliation and disclosures regarding state and local tax payments. Our effective date for adoption of this ASU is our fiscal year ending November 28, 2026. We are evaluating the impact the new disclosure guidance will have on our Consolidated Finance Statements.

 

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures. This ASU extends the existing requirements for annual disclosures to quarterly periods, and requires that both annual and quarterly disclosures present segment expenses using line items consistent with information regularly provided to the chief operating decision maker. Our effective date for adoption of this ASU is our fiscal year ending November 29, 2025. We are evaluating the impact the new disclosure guidance will have on our Consolidated Finance Statements.

 

Supplier Finance Program

 

In September 2022, the FASB issued ASU No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. This ASU requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of the financial statements to understand the program's nature, activity during the period, changes from period to period, and potential magnitude. To achieve that objective, the buyer should disclose qualitative and quantitative information about its supplier finance programs. ASU 2022-04 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the requirement on rollforward information which is an annual requirement. During the first quarter of our fiscal year ending November 30, 2024, we adopted ASU 2022-04. We will present the annual roll-forward disclosure requirement within our annual report on Form 10-K.

 

We have agreements with third parties to provide supplier finance programs which facilitate participating suppliers' ability to finance payment obligations of the Company with designated third-party financial institutions. Participating suppliers may, at their sole discretion, elect to finance one or more payment obligations of the Company prior to their scheduled due dates at a discounted price to participating financial institutions. The Company has no economic interest in the sale of these suppliers’ receivables and no direct financial relationship with the financial institutions concerning these services. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under these arrangements. The outstanding payment obligations that were confirmed as valid and remained outstanding as of June 1, 2024 were approximately $4,710. These obligations under the Company’s supplier finance programs are included in Accounts Payable in the Consolidated Balance Sheets, and the associated payments are reflected in the cash flows from operating activities section of the Consolidated Statements of Cash Flows.

 

8

 

Recently issued accounting standards or pronouncements not disclosed above have been excluded as they are not relevant to the company.

 

 

Note 2: Acquisitions

 

ND Industries, Inc. 

 

On May 20, 2024, we acquired the assets of ND Industries, Inc. (“ND Industries”) for a base purchase price of $255,734 which was funded through borrowings on our credit facility and existing cash. This includes a holdback amount of $1,446 that will be paid on the 4-month anniversary of the closing date. ND Industries, headquartered in Clawson, Michigan, is a leading provider of specialty adhesives and fastener locking and sealing solutions serving customers in the automotive, electronics, aerospace and other industries. The acquisition of ND Industries is expected to accelerate the realization of our top growth priorities, consistent with our strategy to proactively drive capital allocation to the highest margin, highest growth market segments within the functional coatings, adhesives, sealants and elastomer industry. The acquisition fair value measurement was preliminary as of June 1, 2024. ND Industries is included in our Engineering Adhesives operating segment.

 

The following table summarizes the fair value measurement of the assets acquired and liabilities assumed as of the date of acquisition:

 

  

Amounts

 

Current assets

 $15,417 

Property, plant and equipment

  21,888 

Goodwill

  89,825 

Other intangibles

    

Customer relationships

  113,200 

Trademarks/trade names

  4,800 

Technology

  11,800 

Other assets

  662 

Current liabilities

  (1,442)

Other liabilities

  (416)

Total

 $255,734 

 

The expected useful lives of the acquired intangible assets are 12 years. Based on the fair value measurement of the assets acquired and liabilities assumed, we allocated $89,825 to goodwill for the expected synergies from combining ND Industries with our existing business. Such goodwill is deductible for tax purposes. The goodwill was assigned to our Engineering Adhesives operating segment.

 

Sanglier Ltd.

 

On September 8, 2023, we acquired the assets of Sanglier Ltd. (“Sanglier”) for a base purchase price of 13,361 British pound sterling, or approximately $16,660 which was funded through existing cash. This includes a holdback amount of 2,100 British pound sterling that will be paid on the 18-month anniversary of the closing date. Sanglier, headquartered in Mansfield, United Kingdom, is a manufacturer and filler of sprayable (aerosol and cannister) industrial adhesives. The acquisition of Sanglier expands our innovation capabilities and product portfolio across the United Kingdom and Europe transforming adhesives applications to enable sprayable delivery providing end users with an opportunity to greatly improve labor efficiency. The acquisition fair value measurement was preliminary as of June 1, 2024 and includes intangible assets of $7,354, goodwill of $3,362 and other net assets of $5,944. Sanglier is included in our Construction Adhesives operating segment.

 

Adhezion Biomedical LLC

 

On June 23, 2023, we acquired Adhezion Biomedical LLC (“Adhezion”) for a base purchase price of $80,802 which was funded through borrowings on our credit facility. This includes a holdback amount of $780 that will be paid on the 12-month anniversary of the closing date. The agreement includes a payment of contingent consideration up to $15,000 following the completion of certain performance goals and conditions. Adhezion, headquartered in Wyomissing, Pennsylvania, is a manufacturer of cyanoacrylate-based healthcare adhesives and infection prevention products. The acquisition of Adhezion positions us for expansion in the healthcare adhesives industry and creates a solid, unique platform from which to scale and innovate in the healthcare adhesives industry. The acquisition fair value measurement is final as of June 1, 2024 and includes intangible assets of $38,500, goodwill of $37,589 and other net assets of $4,713. Goodwill represents expected synergies from combining Adhezion with our existing business. The amount of goodwill that is deductible for tax purposes is $25,717. Adhezion is included in our Hygiene, Health and Consumable Adhesives operating segment.

 

XChem International LLC
 

On June 12, 2023, we acquired XChem International LLC ("XChem") for a base purchase price of approximately $14,496 which was funded through borrowings on our credit facility. This includes a holdback amount of $1,650 that will be paid on the 18-month anniversary of the closing date. XChem, headquartered in Ras Al-Khaimah, United Arab Emirates, is a manufacturer of adhesives and sealants for construction-related applications. The acquisition of XChem provides our construction adhesives global business with additional manufacturing presence for certain brands outside the U.S. and broadens our construction adhesives portfolio of highly specified applications and diversifies it toward both non-U.S. and infrastructure-oriented markets. The acquisition fair value measurement is final as of June 1, 2024 and includes intangible assets of $4,600, goodwill of $4,318 and other net assets of $5,578. Goodwill represents expected synergies from combining XChem with our existing business. Goodwill is not deductible for tax purposes. XChem is included in our Construction Adhesives operating segment.

 

Beardow Adams Holdings Ltd.

 

On May 1, 2023, we acquired Beardow Adams Holdings Ltd. (“Beardow Adams”) for a total purchase price of 80,738 British pound sterling, or approximately $100,885, which was funded through borrowings on our credit facility. This includes a holdback amount of 8,000 British pound sterling that will be paid on the 18-month anniversary of the closing date. Beardow Adams, based in the United Kingdom, develops and manufactures adhesives, sealants and coatings, principally in the fields of packaging and related applications. The acquisition of Beardow Adams is expected to accelerate profitable growth in many of our core end markets and generate business synergies through better raw material pricing, production optimization and an expanded distribution platform. The acquisition fair value measurement is final as of June 1, 2024 and includes intangible assets of $35,425, goodwill of $28,148 and other net assets of $37,312. Goodwill represents expected synergies from combining Beardow Adams with our existing business. The amount of goodwill that is deductible for tax purposes is $3,561. The remaining goodwill is not deductible for tax purposes. Beardow Adams is included in our Hygiene, Health and Consumable Adhesives operating segment.

 

9

 

Aspen Research Corporation

 

On January 31, 2023, we acquired the assets of Aspen Research Corporation (“Aspen”) for a total purchase price of $9,761, which was funded through existing cash. This includes a holdback amount of $500 that will be paid on the 18-month anniversary of the closing date. Aspen, located in Maple Grove, Minnesota, is a contract research organization that develops and manufactures innovative solutions for some of the adhesives used in our insulating glass market. Aspen is known for their superior understanding of materials science, engineering and analytical testing and specializes in custom materials manufacturing for chemicals and adhesives products. The acquisition of Aspen is expected to expand our Engineering Adhesives footprint in North America and strengthen our capabilities in the insulating glass market, in addition to bringing additive continuous flow, process manufacturing capabilities that we plan to leverage. The acquisition fair value measurement was final as of December 2, 2023 and includes intangible assets of $4,900, goodwill of $3,832 and other net assets of $1,029. Goodwill represents expected synergies from combining Aspen with our existing business. Goodwill is deductible for tax purposes. Aspen is included in our Engineering Adhesives operating segment.

 

Lemtapes Oy


On December 15, 2022, we acquired Lemtapes Oy (“Lemtapes”) for a total purchase price of $8,922 Euro, or approximately $9,482 which was funded through existing cash. This includes a holdback amount of 850 Euro that will be paid on the 18-month anniversary of the closing date. Lemtapes, located in Valkeakoski, Finland, is a solutions provider of ecological, innovative tapes and adhesives for the packaging and plywood industries. The acquisition of Lemtapes is expected to reinforce our strategic position in Europe, especially for our adhesives coated solutions products. This acquisition will also accelerate our growth strategy of fast-growing, high margin businesses while adding technology capabilities and strong customer relationships. The acquisition fair value measurement was final as of December 2, 2023 and includes intangible assets of $5,526, goodwill of $3,028 and other net assets of $928. Goodwill represents expected synergies from combining Lemtapes with our existing business. Goodwill is not deductible for tax purposes. Lemtapes is included in our Hygiene, Health and Consumable Adhesives operating segment.

 

All acquisitions, individually and in the aggregate, are not material and therefore pro forma financial information is not provided.

 

 

Note 3: Restructuring Actions

 

During fiscal year 2023, the Company approved restructuring plans (the "Plans") related to organizational changes and other actions to optimize operations and integrate acquired businesses. The Plans were implemented in the second quarter of fiscal year 2023 and are currently expected to be completed during fiscal year 2026, with the majority of the charges recognized and cash payments occurring in fiscal 2023 and 2024. In implementing the Plans, the Company currently expects to incur pre-tax costs of approximately $39,100 to $44,100 for severance and related employee costs globally, other restructuring costs related to the streamlining of processes and the payment of anticipated income taxes in certain jurisdictions related to the Plans. 

 

The following table summarizes the pre-tax distribution of charges under these restructuring plans by income statement classification:

 

  

Three Months Ended

  

Six Months Ended

 
  

June 1, 2024

  

June 3, 2023

  

June 1, 2024

  

June 3, 2023

 

Cost of sales

 $1,279  $2,784  $4,194  $5,085 

Selling, general and administrative

  1,279   2,618   2,444   3,243 
  $2,558  $5,402  $6,638  $8,328 

 

The restructuring charges are all recorded in Corporate Unallocated for segment reporting purposes.

 

A summary of the restructuring liability is presented below:

 

  

Employee-Related

  

Asset-Related

  

Other

  

Total

 

Balance at December 3, 2022

 $57  $-  $-  $57 

Expenses incurred

  22,731   1,369   487   24,587 

Non-cash charges

  -   (1,369)  (453)  (1,822)

Cash payments

  (9,802)  -   (34)  (9,836)

Foreign currency translation

  (1,263)  -   -   (1,263)

Balance at December 2, 2023

 $11,723  $-  $-  $11,723 

Expenses incurred

  2,918   3,607   113   6,638 

Non-cash charges

  -   (3,607)  (102)  (3,709)

Cash payments

  (9,017)  -   (11)  (9,028)

Foreign currency translation

  (140)  -   -   (140)

Balance at June 1, 2024

 $5,484  $-  $-  $5,484 

 

Non-cash charges primarily include accelerated depreciation resulting from the cessation of use of certain long-lived assets and inventory disposals. Restructuring liabilities have been classified as a component of other accrued expenses on the Consolidated Balance Sheets.

 

 

Note 4: Inventories

 

The composition of inventories is as follows:

 

  

June 1,

  

December 2,

 
  

2024

  

2023

 

Raw materials

 $225,908  $206,140 

Finished goods

  270,177   235,900 

Total inventories

 $496,085  $442,040 

 

 

Note 5: Goodwill and Other Intangible Assets

 

The goodwill activity by reportable segment for the six months ended June 1, 2024 is presented below:

 

  

Hygiene, Health

             
  

and Consumable

  

Engineering

  

Construction

     
  

Adhesives

  

Adhesives

  

Adhesives

  

Total

 

Balance at December 2, 2023

 $402,598  $651,145  $432,769  $1,486,512 

Acquisitions

 $1,674  $89,825  $2,897   94,396 

Foreign currency translation effect

 $(719) $(1,999) $107   (2,611)

Balance at June 1, 2024

 $403,553  $738,971  $435,773  $1,578,297 

 

Balances of amortizable identifiable intangible assets, excluding goodwill and other non-amortizable intangible assets, are as follows:

 

  

June 1, 2024

 
  

Purchased

                 
  

Technology

  

Customer

             

Amortizable Intangible Assets

 

and Patents

  

Relationships

  

Trade Names

  

Other

  

Total

 

Original cost

 $144,456  $1,068,558  $62,944  $9,887  $1,285,845 

Accumulated amortization

  (52,568)  (387,964)  (26,320)  (6,402)  (473,254)

Net identifiable intangibles

 $91,888  $680,594  $36,624  $3,485  $812,591 

 

  

December 2, 2023

 
  

Purchased

                 
  

Technology

  

Customer

             

Amortizable Intangible Assets

 

and Patents

  

Relationships

  

Trade Names

  

Other

  

Total

 

Original cost

 $144,763  $986,470  $58,484  $10,911  $1,200,628 

Accumulated amortization

  (59,631)  (382,220)  (23,099)  (7,012)  (471,962)

Net identifiable intangibles

 $85,132  $604,250  $35,385  $3,899  $728,666 

 

Amortization expense with respect to amortizable intangible assets was $19,219 and $19,130 for the three months ended June 1, 2024 and June 3, 2023, respectively, and was $39,574 and $37,813 for the six months ended June 1, 2024 and June 3, 2023  

 

Estimated aggregate amortization expense based on the current carrying value of amortizable intangible assets for the next five fiscal years is as follows:

 

  

Remainder

                     

Fiscal Year

 

2024

  

2025

  

2026

  

2027

  

2028

  

Thereafter

 

Amortization expense

 $40,716  $87,399  $80,670  $77,359  $77,103  $449,344 

 

11

 

The above amortization expense forecast is an estimate. Actual amounts may change from such estimated amounts due to fluctuations in foreign currency exchange rates, additional intangible asset acquisitions, potential impairment, accelerated amortization or other events.

 

Non-amortizable intangible assets as of  June 1, 2024 and December 2, 2023 were $472 and $474, respectively, and relate to trademarks and trade names. The change in non-amortizable assets as of June 1, 2024 compared to December 2, 2023 was due to changes in foreign currency exchange rates.

 

 

Note 6: Long-Term Debt

 

On March 4, 2024, we entered into a Refinancing and Incremental Amendment (the “Refinancing and Incremental Amendment”), which amends the Second Amended and Restated Credit Agreement dated as of February 15, 2023, as previously amended. Pursuant to the Refinancing and Incremental Amendment, the existing Term B loans under the Credit Agreement were refinanced by “Refinancing Loans” (as defined in the Credit Agreement) in the principal amount of $794,000 (the “Amended TLB”), certain lenders party to the Refinancing and Incremental Amendment made additional Term B loans to the Company in the principal amount of $200,000, thereby increasing the aggregate principal amount of the Amended TLB to $994,000, and the interest rate margins applicable to the Amended TLB were decreased by 25 basis points (0.25% per annum) to 200 basis points for SOFR rate loans and 100 basis points for prime rate loans. The additional $200,000 of proceeds will be used to finance our working capital needs and for general corporate purposes, including permitted acquisitions. Interest on Term Loan B borrowings are payable at SOFR plus an interest rate spread of 200 basis points with a SOFR floor of 50 basis points (7.33 percent at June 1, 2024). The maturity date of February 15, 2030 remains unchanged. The commitment fee rates and interest rates applicable to the revolving credit facility and the Term Loan A facility remain unchanged.

 

 

Note 7: Components of Net Periodic Benefit related to Pension and Other Postretirement Benefit Plans

 

  

Three Months Ended June 1, 2024 and June 3, 2023

 
                  

Other

 
  

Pension Benefits

  

Postretirement

 
  

U.S. Plans

  

Non-U.S. Plans

  

Benefits

 

Net periodic (benefit) cost:

 

2024

  

2023

  

2024

  

2023

  

2024

  

2023

 

Service cost

 $-  $-  $347  $413  $-  $- 

Interest cost

  3,464   3,475   1,560   1,410   291   301 

Expected return on assets

  (6,555)  (7,205)  (1,627)  (1,730)  (2,727)  (2,465)

Amortization:

                        

Prior service cost

  -   -   16   15   -   - 

Actuarial loss

  1,159   635   510   491   -   - 

Net periodic (benefit) cost

 $(1,932) $(3,095) $806  $599  $(2,436) $(2,164)

 

  

Six Months Ended June 1, 2024 and June 3, 2023

 
                  

Other

 
  

Pension Benefits

  

Postretirement

 
  

U.S. Plans

  

Non-U.S. Plans

  

Benefits

 

Net periodic (benefit) cost:

 

2024

  

2023

  

2024

  

2023

  

2024

  

2023

 

Service cost

 $-  $-  $697  $833  $-  $- 

Interest cost

  6,928   6,951   3,129   2,846   583   602 

Expected return on assets

  (13,110)  (14,412)  (3,264)  (3,492)  (5,454)  (4,929)

Amortization:

                        

Prior service (benefit) cost

  -   -   32   30   -   - 

Actuarial loss (gain)

  2,318   1,271   1,024   990   -   - 

Net periodic (benefit) cost

 $(3,864) $(6,190) $1,618  $1,207  $(4,871) $(4,327)

 

Service cost is included with employee compensation cost in cost of sales and selling, general and administrative expenses in the Consolidated Statements of Income. The components of our net periodic defined benefit pension and postretirement benefit costs other than service cost are presented in other income, net in the Consolidated Statements of Income.

 

 

Note 8: Accumulated Other Comprehensive Income (Loss)

 

The following table provides details of total comprehensive income (loss): 

 

  

Three Months Ended June 1, 2024

  

Three Months Ended June 3, 2023

 
              

Non-

              

Non-

 
              

controlling

              

controlling

 
  

H.B. Fuller Stockholders

  

Interest

  

H.B. Fuller Stockholders

  

Interest

 
  

Pre-tax

  

Tax

  

Net

  

Net

  

Pre-tax

  

Tax

  

Net

  

Net

 

Net income attributable to H.B. Fuller and non-controlling interest

         $51,264  $33          $40,401  $21 

Foreign currency translation¹

 $(26,894) $-   (26,894)  (32) $26,425  $-   26,425   (15)

Defined benefit pension plans adjustment²

  555   (136)  419   -   1,151   (293)  858   - 

Interest rate swaps³

  13,493   (3,297)  10,196   -   (12,584)  3,096   (9,488)  - 

Net investment hedges³

  163   (40)  123   -   (7,141)  1,757   (5,384)  - 

Other comprehensive (loss) income

 $(12,683) $(3,473) $(16,156) $